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Nonimmune Hydrops Fetalis
Heather Walker, BSN, RN, CCRN
Otterbein University, Westerville, Ohio
Hydrops fetalis is an excessive
accumulation of fluid within the fetal
extravascular compartments and body
cavities generally characterized by:
•
placental enlargement
•
ascites
•
pericardial effusions
•
pleural effusions
(Bellini, 2014, p. 1082).
Nonimmune hydrops fetalis (NIHF)
develops as a result of one or more
nonimmune factors, distinguishing it
from immune hydrops fetalis that
results from a maternal antigen-body
fetal antigen-mediated red blood cell
hemolysis (Randenberg, 2010, p. 281).

Pathophysiology
The main pathophysiologic factor
implicated in the development of
NIHF is abnormal fluid movement
between the plasma and tissues
(Randenberg, 2010, p. 281). Any
disruption in the balance of fluid can
result in excess fluid in both the body
tissues and cavities, thus leading to
edema, ascites, and pleural and
pericardial effusions. Perinatal
mortality with this severe diagnosis
is high, between 50-98% (Kayiran,
2013, p. 168). Four main theories
have been suggested to explain the
distribution of fluids that occur with
hydrops fetalis:
1.
an increase in hydrostatic
capillary pressure (resulting
from heart failure or from
obstruction of venous return)
2.
a reduction in plasma osmotic
pressure (from decreased
albumin production or
increased albumin loss)
3.
obstruction of lymphatic flow
4.
damage to peripheral capillary
integrity
(Randenberg, 2014, p. 282).

Cardiac Anomalies
Fetal echocardiography should be
performed when the diagnosis is made
of hydrops fetalis since fetal cardiac
anomalies are among the highest cause
of NIHF (Norton, 2015, p. 25). The
incidence of cardiac defects and rhythm
abnormalities make up 19-25% of NIHF
(Kayiran, 2013, p. 168). The cardiac
anomaly is present due to the
development of fetal heart failure; this
can be a rhythm issue or a structural
defect. Fetal supraventricular
tachycardia is the most common
tachyarrhythmia causing NIHF,
accounting for 35-60% of all cases
presenting with rhythm disturbances
(Kayiran, 2013, p. 169). Fetal
supraventricular tachycardia results in
decreased ventricular filling time during
diastole which further reduces cardiac
output resulting in poor perfusion,
inadequate tissue oxygenation, elevated
central venous pressure, and hepatic
venous congestion (Randenberg, 2010,
p. 287). The treatment of choice for fetal
arrhythmias is the administration of
medications to the mother such as
digoxin or beta-blockers. Structural
heart defects can affect both the right
and left side of the heart in an infant
born with hyrdops fetalis. Right-sided
heart defects such as Hypoplastic right
heart syndrome, Tetralogy of Fallot, and
Ebstein’s anomaly all result in rightsided outflow tract obstruction thus
impeding blow flow to the lungs. Leftsided heart defects such as Hypoplastic
left heart syndrome, and aortic valve
abnormalities all result in left-sided
outflow tract obstruction resulting in
severely decreased oxygen rich blood
flow to the body. All of these structural
heart defects associated with NIHF are
indicative of open-heart surgical
intervention, most of them within
several days of life. Poor prognosis of
survival of NIHF is associated with
structural cardiac defects and fetal
arrhythmias diagnosed before 24 weeks
gestation (Turgal, 2015, p. 357).

Clinical
Management

Clinical management is indicative for the
fetus and the infant in the setting of
NIHF. Once a prenatal diagnosis has
been made, focus is aimed at the
coordination and collaboration with
obstetrics/gynecology, social work,
cardiology, genetics, and neonatology
specialists. The information gathered is
used to help with education and possible
causes so the family can make an
informed choice regarding treatment
options. Supportive care measures and
education are vital goals in the prenatal
period. The parents must be kept
informed of what to expect during labor
and delivery and especially in the
neonatal management in the delivery
room; particularly subsequent tests and
procedures.
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Nursing Implications
Nursing implications are directed at maximizing neonatal resuscitative measures.
Preventing cold stress with the use of radiant warmers and a warmed room will help
in decreasing added stress to an already compromised infant. Respiratory support
with the help of endotracheal intubation, high peak inspiratory pressures and 100%
FiO2, umbilical arterial and venous catheter placement for management of
hemodynamics and blood gas interpretation, helping in the procedure of bilateral
thorancentesis for fluid removal in the pleural space, initiation of volume resuscitation
with albumin or other colloids, and cardiovascular support with inotropes to improve
cardiac output are all vital by nursing and medical staff to aid in the support and
survival of NIHF. Neonatal management requires a skilled and coordinated
resuscitative team by a well-equipped birthing hospital and neonatal intensive care
unit.

Conclusion
In conclusion, despite many advances made in the treatment, management and
diagnosis, NIHF still carries a high mortality rate. Further research is still needed to
help with the management and treatment of NIHF to decrease intrauterine and
perinatal mortality.
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